Enterprise Value
30.14M
Cash
29.02M
Avg Qtr Burn
-4.545M
Short % of Float
3.59%
Insider Ownership
4.76%
Institutional Own.
19.09%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
REZZAYO (Rezafungin) Details Infectious disease, Fungal infections, Candidemia | Approved Quarterly sales | |
Rezafungin Details Infectious disease, Fungal infections | Phase 3 Update | |
CD388 (DFCs) Details Infectious disease, Influenza | Phase 2b Initiation |